Uncategorized
CJC-1295 no DAC 2mg/5mg – GH Releasing Peptide for Pulsed Research
🧬 CJC-1295 no DAC 2mg/5mg – Int
Category: Growth Hormone Releasing Hormone (GHRH) Analogs
Form: Lyophilized Peptide
Strengths Available: 2mg & 5mg vials
Origin: International
🧠 What is CJC-1295 no DAC?
CJC-1295 no DAC (Modified GRF 1-29) is a short-acting growth hormone-releasing hormone (GHRH) analog that stimulates natural GH production by the pituitary. Unlike the DAC version, this variant has no Drug Affinity Complex (DAC), resulting in a shorter half-life (~30 minutes). This makes it ideal for pulsatile GH release, especially when paired with GHRPs like Ipamorelin or GHRP-6.
Researchers use CJC no DAC to mimic natural GH rhythms, offering a safer, more physiological approach to GH stimulation in comparison to synthetic HGH.
✅ Key Research Benefits
- 💉 Stimulates natural GH secretion in pulses
- 🧬 Supports lean muscle development & fat metabolism
- 🔄 Pairs synergistically with GHRPs for enhanced GH output
- 💤 May improve sleep quality and recovery
- 🛡️ Supports anti-aging, immune function, and cellular regeneration
⚙️ Product Specifications
Attribute | Detail |
---|---|
Peptide | CJC-1295 without DAC (Modified GRF 1-29) |
Form | Freeze-dried (lyophilized) powder |
Available Strengths | 2mg or 5mg per vial |
Recommended Diluent | Bacteriostatic Water |
Storage (dry) | Room temperature (cool, dark place) |
Storage (reconstituted) | Refrigerate at 2–8°C |
📋 Suggested Research Protocol (Example Use)
- Reconstitution:
- 2mg vial with 2ml = 1mg/ml concentration
- 5mg vial with 2.5ml = 2mg/ml concentration
- Typical Dosing:
- 100–200mcg per administration
- 2–3 times daily (pre-meal or pre-sleep)
- Often paired with GHRP-6, GHRP-2, or Ipamorelin for a synergistic GH pulse
- Common Stack:
- CJC-1295 no DAC + GHRP-6 or Ipamorelin
- Ideal for studies on GH pulsatility, recovery, and lean body mass
⚠️ For Research Use Only
This peptide is not for human or veterinary consumption. It is strictly for laboratory research purposes under controlled conditions.